Signal transduction mechanism of cell death-role of kinase cascade.

细胞死亡的信号转导机制——激酶级联的作用。

基本信息

  • 批准号:
    07670706
  • 负责人:
  • 金额:
    $ 1.6万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    1995
  • 资助国家:
    日本
  • 起止时间:
    1995 至 1996
  • 项目状态:
    已结题

项目摘要

To understand molecular mechanism of many neurodegenerative disorders, we should elucidate how neurons and muscle cells die and the signals for cell death in such diseases. Accumulating evidences have suggested that apoptotic cell death can occur in patients' brain from some neurodegenerative disorders. We have been involved in the study of the intracellular signal transduction pathway of apoptotic cell death in terms of intracellular protein kinase casccade. In this project, we tried to develope the model system where cells die through apoptotic mechanism in neuronal culture systems and examine the intracellular signal transduction pathway of apoptotic cell death. For these purposes, we found that L6 myocytes are killed by HMG-CoA reductase inhibitor (HCRI), widely used medicine for the treatment of hypercholesteroraemia, involving the induction of apoptotic mechanism. Hydrophobic derivative of HCRIs, simvastatin kills L myocytes at the concentration of 30 ug/ml and causes internucleo … More somal DNA fragmentation and tyrosine phosphorylation reaction of several cellular proteins. Herbimycin A or genistein, a potent inhibitor of protein tyrosine kinase activity prevented simvastatin-induced apoptotic cell death. In the next step, we tried to identify the protein which got tyrosine phosphorylated in response to simvastatin treatment and succeeded in identifying one of such proteins. Phospholipase C-gamma 1 was found to be tyrosine-phosphorylated in simvastatin-treated cells. Tyrosien phosphorylation of PLC-gamma1 was evident as early as 2 min after addition of simvastatin into culture medium and reached maximum at 10 min after its addition. Heretofore, PLC-gamma1 is activated when it gets tyrosine-phosphorylated, although tyrosine phosphorylation is not the only way for the activation. Therefore, we tried to check whether simvastatin induces PI turnove in simvastatin treated cells. Intracellular concentration of IP3 increased up to 3-fold than the basal level at 10 min after addition of simvastatin. U73122, a potent inhibitor of PLC,clear inhibited simvastatin-induced cell death. These results indicate the special role of tyrosine phosphoryaltion and PLC activity in apoptotic cell death of muscle cells. Less
为了了解许多神经退行性疾病的分子机制,我们应该阐明这些疾病中神经元和肌肉细胞是如何死亡的以及细胞死亡的信号。越来越多的证据表明,某些神经退行性疾病患者的脑组织中可发生凋亡性细胞死亡。我们参与了细胞内蛋白激酶级联的凋亡细胞死亡的细胞内信号转导途径的研究。本研究试图建立神经元培养系统中细胞通过凋亡机制死亡的模型系统,并研究凋亡性细胞死亡的细胞内信号转导途径。为了这些目的,我们发现L 6心肌细胞被HMG-CoA还原酶抑制剂(HCRI)杀死,HCRI是广泛用于治疗高胆固醇血症的药物,涉及诱导凋亡机制。辛伐他汀是HCRIs的疏水衍生物,在30 μ g/ml浓度下杀死L型心肌细胞,并引起核内 ...更多信息 体DNA断裂和几种细胞蛋白酪氨酸磷酸化反应。除草霉素A或染料木黄酮,一种有效的蛋白酪氨酸激酶活性抑制剂,阻止辛伐他汀诱导的细胞凋亡。在下一步中,我们试图鉴定在辛伐他汀治疗后酪氨酸磷酸化的蛋白质,并成功地鉴定了这样的蛋白质之一。发现磷脂酶C-γ 1在辛伐他汀处理的细胞中被酪氨酸磷酸化。在培养基中加入辛伐他汀后2 min,PLC-γ 1的酪氨酸磷酸化明显,并在加入辛伐他汀后10 min达到最大值。因此,PLC-γ 1在酪氨酸磷酸化时被激活,尽管酪氨酸磷酸化不是激活的唯一途径。因此,我们试图检查辛伐他汀是否在辛伐他汀处理的细胞中诱导PI翻转。在加入辛伐他汀后10分钟,细胞内IP 3浓度比基础水平增加了3倍。U 73122是一种有效的PLC抑制剂,明显抑制辛伐他汀诱导的细胞死亡。这些结果表明酪氨酸磷酸化和PLC活性在肌细胞凋亡中的特殊作用。少

项目成果

期刊论文数量(14)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
T Mutoh, M Kuriyama: "Lysosomal storage dieases.--Methods for mass screening" Jap Clin. 53. 2933-2937 (1995)
T Mutoh,M Kuriyama:“溶酶体贮积病。--大规模筛选方法”Jap Clin。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
M Pu et al: "Mercuric chloride mediates a protein sulfhydryl modification based pathway of signal transduction for activating Src kinase" J Cell Biochem. 63. 104-114 (1996)
M Pu 等人:“氯化汞介导基于蛋白质巯基修饰的信号转导途径,用于激活 Src 激酶”J Cell Biochem。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
M Hirayama: "Chorea-acanthocytosis with polyelonal antibodies to ganglioside GMl" J Neurol Sci. (in press).
M Hirayama:“舞蹈症-棘红细胞增多症与神经节苷脂 GM1 多克隆抗体”J Neurol Sci。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Pu M.et al.: "Evidence of a novel redox-linked activation mechanisin for the Sro Kinase which is independent of tyrosine 527-mediated regulation" Oncogene. 13. 2615-2622 (1996)
Pu M.等人:“Sro 激酶的新型氧化还原连接激活机制的证据,该机制独立于酪氨酸 527 介导的调节”Oncogene。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Hirayama M.et al.: "Chorea-acanthocytosis with polyolonal antibodies to ganglioside GMI" J Neurol Sci. (in press).
Hirayama M.et al.:“舞蹈病-棘红细胞增多症与神经节苷脂 GMI 多克隆抗体”J Neurol Sci。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MUTOH Tatsuro其他文献

MUTOH Tatsuro的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MUTOH Tatsuro', 18)}}的其他基金

Membrane rafts impairments in neurological disorders showing dementia
神经系统疾病中的膜筏损伤显示痴呆
  • 批准号:
    25461295
  • 财政年份:
    2013
  • 资助金额:
    $ 1.6万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Elucidation of the molecular mechanisms of anti-ganglioside antibody-induced neuronal dysfunction
阐明抗神经节苷脂抗体诱导神经元功能障碍的分子机制
  • 批准号:
    17590902
  • 财政年份:
    2005
  • 资助金额:
    $ 1.6万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Signal transduction of neuronal survival and death : cross talk
神经元生存和死亡的信号转导:串扰
  • 批准号:
    13670637
  • 财政年份:
    2001
  • 资助金额:
    $ 1.6万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Intracellular signal transduction mechanims of neuronal survival and death
神经元生存和死亡的细胞内信号转导机制
  • 批准号:
    11670616
  • 财政年份:
    1999
  • 资助金额:
    $ 1.6万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Biochemical and molecular mechanism for the activation of neurotrophin receptors by Ganglioside GM1
神经节苷脂GM1激活神经营养素受体的生化和分子机制
  • 批准号:
    09670648
  • 财政年份:
    1997
  • 资助金额:
    $ 1.6万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
The study of the intracellular signal transduction pathway for cell proliferation and differentiation - Modulation by gangliosides.
细胞增殖和分化的细胞内信号转导途径的研究——神经节苷脂的调节。
  • 批准号:
    03670415
  • 财政年份:
    1991
  • 资助金额:
    $ 1.6万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)

相似海外基金

HMG-CoA reductase inhibitor, tea polyphenols and pancreatic cancer prevention
HMG-CoA还原酶抑制剂、茶多酚与胰腺癌预防
  • 批准号:
    7434507
  • 财政年份:
    2007
  • 资助金额:
    $ 1.6万
  • 项目类别:
HMG-CoA reductase inhibitor, tea polyphenols and pancreatic cancer prevention
HMG-CoA还原酶抑制剂、茶多酚与胰腺癌预防
  • 批准号:
    7257549
  • 财政年份:
    2007
  • 资助金额:
    $ 1.6万
  • 项目类别:
Effects of HMG-coA Reductase Pathway Inhibitors on GCAD
HMG-coA 还原酶途径抑制剂对 GCAD 的影响
  • 批准号:
    7346990
  • 财政年份:
    2006
  • 资助金额:
    $ 1.6万
  • 项目类别:
HMG CoA REDUCTASE AND COX2 INHIBITORS IN COLON CANCER
HMG CoA 还原酶和 COX2 抑制剂在结肠癌中的作用
  • 批准号:
    7026972
  • 财政年份:
    2002
  • 资助金额:
    $ 1.6万
  • 项目类别:
HMG CoA REDUCTASE AND COX2 INHIBITORS IN COLON CANCER
HMG CoA 还原酶和 COX2 抑制剂在结肠癌中的作用
  • 批准号:
    6622903
  • 财政年份:
    2002
  • 资助金额:
    $ 1.6万
  • 项目类别:
HMG-CoA Reductase and Polyamine Inhibitors for Prevention of Colorectal Cancer
HMG-CoA 还原酶和多胺抑制剂预防结直肠癌
  • 批准号:
    8244563
  • 财政年份:
    2002
  • 资助金额:
    $ 1.6万
  • 项目类别:
HMG CoA REDUCTASE AND COX2 INHIBITORS IN COLON CANCER
HMG CoA 还原酶和 COX2 抑制剂在结肠癌中的作用
  • 批准号:
    6949821
  • 财政年份:
    2002
  • 资助金额:
    $ 1.6万
  • 项目类别:
HMG-CoA Reductase and Polyamine Inhibitors for Prevention of Colorectal Cancer
HMG-CoA 还原酶和多胺抑制剂预防结直肠癌
  • 批准号:
    7992104
  • 财政年份:
    2002
  • 资助金额:
    $ 1.6万
  • 项目类别:
HMG-CoA Reductase and Polyamine Inhibitors for Prevention of Colorectal Cancer
HMG-CoA 还原酶和多胺抑制剂预防结直肠癌
  • 批准号:
    8624661
  • 财政年份:
    2002
  • 资助金额:
    $ 1.6万
  • 项目类别:
HMG CoA REDUCTASE AND COX2 INHIBITORS IN COLON CANCER
HMG CoA 还原酶和 COX2 抑制剂在结肠癌中的作用
  • 批准号:
    6864445
  • 财政年份:
    2002
  • 资助金额:
    $ 1.6万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了